Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Larry Fox

Pediatric Endocrinology Jacksonville, FL Medical Doctor

NPI 1639284615 CMS profile 209628

807 Childrens Way, Jacksonville, FL 32207

Open in the dashboard

General payments

$2,479

56 records reported · program years 2019–2024

Research payments

$4,470

Paid to them · 3 records reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$845,083 paid to institutions, not to them · program years 2019–2025

Through program year 2024, Larry Fox of Jacksonville, FL is reported in the CMS Open Payments database as having received $2,479 across 56 general payments and $4,470 in research payments paid to them. Separately, studies naming them as principal investigator received $845,083 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 79th percentile of Pediatric Endocrinology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $135 5
2023 General $194 9
2022 General $221 12
2022 Research $3,200 1
2021 General $214 11
2021 Research $940 1
2020 General $234 5
2020 Research $330 1
2019 General $1,481 14

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Larry Fox
  • Pediatric Endocrinology median
  • Middle half of Pediatric Endocrinology
  • National median

In program year 2025, general payments to Larry Fox were reported at $0. Among 971 Pediatric Endocrinology profiles paid that year, the median was $293 and the middle half received between $106 and $1,640.

Show as a table
Year Larry Fox Pediatric Endocrinology median Middle half National median
2019 $1,481 $196 $68–$845 $163
2020 $234 $124 $37–$722 $114
2021 $214 $134 $35–$691 $132
2022 $221 $177 $47–$726 $149
2023 $194 $236 $75–$887 $160
2024 $135 $259 $91–$979 $164
2025 $0 $293 $106–$1,640 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Pfizer Inc. $1,226 4 payments
  2. Abbott Laboratories $502 26 payments
  3. Dexcom, Inc. $221 4 payments
  4. Insulet Corporation $119 5 payments
  5. Medtronic, Inc. $99 4 payments
  6. Tandem Diabetes Care, Inc. $76 1 payment
  7. AbbVie, Inc. $52 2 payments
  8. Sanofi-Aventis U.S. LLC $40 1 payment
  9. Novo Nordisk Inc $38 3 payments
  10. Ultragenyx Pharmaceutical Inc. $30 1 payment
  11. Other $76 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Food and Beverage $1,531 52 payments
  2. Travel and Lodging $918 3 payments
  3. Education $30 1 payment
Products named General payments · program years 2019–2024
  1. GENOTROPIN $777 3 payments
  2. FreeStyle Libre 3 $202 9 payments
  3. FreeStyle Libre 2 $195 11 payments
  4. DEXCOM CGM $115 3 payments
  5. Dexcom G6 CGM System $106 1 payment
  6. t:slim X2 insulin pump $76 1 payment
  7. Omnipod $75 2 payments
  8. Minimed 670G System $64 2 payments
  9. LUPRON DEPOT $52 2 payments
  10. FreeStyle Libre $48 3 payments
  11. Other $332 19 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2024
  1. Pfizer Inc. $4,470 3 payments

Records

59 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Endocrinology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record